- Home
- Clinical Trials
Coeliac Disease Study Wellington 102-3
Coeliac Disease Study
Wellington
Do you have coeliac disease and are you tired of being on a gluten free diet?
Momentum Clinical Research are evaluating an investigational treatment that aims to prevent reactions to gluten.
Participants will be compensated for reasonable expenses associated with study visits.
Join our research study and help find a potential new treatment for people living with coeliac disease.
Description
What to expect
Study details
Ages
18 to 70 years old
Duration
Up to 33 weeks with approximately 10-12 clinic visits
Compensation
Participants will be compensated for reasonable expenses associated with visits
Eligibility Criteria
You may be eligible to join this study if you:
- Are 18 to 70 years old
- Have had a biopsy confirmed diagnosis for coeliac disease
- Have followed a strict gluten free diet for 12 months or longer
Other eligibility criteria applies. Our team will assess if this study is the right fit for you.
Locations
Description
Coeliac Disease is an autoimmune disorder that develops in genetically predisposed people. It involves an immune response to gluten containing foods such as wheat, barley and rye found in bread, cereals, pasta and baked goods.
The only current treatment is to maintain a lifelong strict gluten free diet which can be extremely challenging and near impossible. The inevitable breaks in the diet result in uncomfortable symptoms such as diarrhoea, abdominal pain and bloating that disrupt everyday life. On top of this, availability of gluten free food varies between countries and regions and the cost is significantly higher than equivalent gluten containing food.
As such, there is significant unmet medical need for safe and effective alternative treatments in addition to dietary avoidance of gluten.
What to expect
This research study is investigating the effects of an investigational treatment on coeliac disease and specific immune and gut health markers during and after a gluten challenge.
Participants will receive an intravenous infusion of either the investigational treatment or a placebo (a substance with no active ingredients) once a week for eight doses over an 11-week period. Starting in Week 4, participants will begin a gluten challenge by consuming a small, measured amount of gluten daily for six weeks.
The study medication aims to reduce the body’s immune response to gluten which could represent a potential new treatment option for people living with coeliac disease.
Why join this clinical research study?
- Access a potential new treatment that may reduce gluten-related damage
- Receive close medical monitoring throughout the study
- Contribute to the development of potential treatments beyond gluten avoidance
Apply now
Fill out your details, and our team will be in touch to discuss your potential involvement in this study and answer any questions you may have.
Momentum Clinical Research NZ is a member of the Global Site Holdings Group. Global Site Holdings Pty Limited ACN 668 977 062 trading as Momentum Clinical Research ABN 51 668 977 062 and our related entities (we, us, our), will use the Personal Information you have provided in the above form to review and respond to your enquiry, to contact you about any future trials or studies you may be eligible for, and otherwise in accordance with our Privacy Policy and as required and authorised by law. We may not be able to provide you with a complete response or a response at all to your enquiry if you do not provide the requested information. Our Privacy Policy also contains further information about how we collect, use, store or disclose your Personal Information, how you may seek access and correction of your Personal Information, and how you may make a complaint about a breach of privacy. If you have questions, please contact us at contact@momentumclinicalresearch.com.